Technetium [99mTc] Generator is used for the preparation of Sodium Pertechnetate [99mTc] Injection.

Sodium Pertechnetate [99mTc] is used as an agent for:

• Brain Imaging,
• Thyroid Imaging,
• Salivary Gland Imaging and
• Blood Pool Imaging

Pethidine 50 mg/mL Solution for Injection ampoules (50 mg/mL & 100 mg/2 mL) are approved for use under Section 19A for the following indications:

• For short term (24 to 36 hours) management of severe pain

• Duodenal ulcer
• Benign gastric ulcer
• Zollinger-Ellison syndrome
• Prevention of relapses of duodenal ulceration
• Short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures

Furosemide (Frusemide) in a high-dosage formulation is intended exclusively for patients with severely impaired renal function. For use under strict medical supervision only within a hospital setting (see Dosage and Administration). High doses of frusemide may be used as an adjuvant treatment of oliguria and in the promotion of diuresis in the treatment of oedema; in selected patients with acute renal failure, e.g. in the post-operative phase and in association with septic infections; in selected patients with chronic renal failure with fluid retention, both in the pre-dialysis phase and when dialysis has become unavoidable, especially in the presence of acute pulmonary oedema; in selected patients with the nephrotic syndrome with severe impairment of renal function e.g. in chronic glomerulonephritis, lupus erythematous and Kimmelstiel-Wilson syndrome. If diuresis is less than 2.5 L / day dialysis has to be used.